Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
25.75
-2.15 (-7.71%)
At close: Oct 2, 2026, 4:00 PM EDT
26.22
+0.47 (1.83%)
After-hours: Oct 2, 2026, 7:32 PM EDT

Nanobiotix Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Nanobiotix stock has a consensus rating of "Strong Buy" and an average price target of $54. The average 1-year stock price forecast is 109.71% higher than the current stock price, while the lowest is $29.58 (+14.87%) and the highest is $69.18 (+168.66%).

Price Target: $54 (+109.71%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$29.58$54$63.25$69.18
Change+14.87%+109.71%+145.63%+168.66%

Analyst Ratings

The average analyst rating for Nanobiotix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Sep '26
Strong Buy666644
Buy000000
Hold001111
Sell000000
Strong Sell000000
Total667755

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Guggenheim
Guggenheim
Buy
Maintains
$64
BuyMaintains$64+148.54%Sep 25, 2026
TD Cowen
TD Cowen
Buy
Maintains
n/a
BuyMaintainsn/an/aSep 25, 2026
UBS
UBS
Hold
Maintains
$30
HoldMaintains$30+16.50%Sep 25, 2026

Financial Forecast

Revenue This Year
29.44M
from 32.59M
Decreased by -9.67%
Revenue Next Year
44.36M
from 29.44M
Increased by 50.69%
EPS This Year
-0.61
from -0.50
EPS Next Year
-0.25
from -0.61
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
2.65M4.78M36.21M-7.19M32.59M29.44M
Revenue Growth
13.85%80.43%658.10%---9.67%
Gross Profit
2.65M4.78M36.21M-7.19M32.59M26.79M
Gross Margin
100.00%100.00%100.00%100.00%100.00%91.00%
Operating Income
-47.17M-45.72M-24.24M-68.26M-10.88M-15.86M
Net Income
-47.00M-57.04M-39.70M-68.13M-23.96M-28.75M
EPS
-----0.50-0.61
Free Cash Flow
-----33.96M-23.80M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High49.0M
Avg29.4M
Low10.0M

Revenue Growth

Revenue Growth202620272028
High
50.4%
Avg
-9.7%
Low
-69.3%

EPS Forecast

EPS202620272028
High-0.31
Avg-0.61
Low-0.91

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-